A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder

Kelesitse Phiri; Jesper Hallas; Marie Linder; Andrea Margulis; Brandon Suehs; Alejandro Arana; Shahram Bahmanyar; Cheryl Enger; Libby Horter; Ingvild Odsbu; Morten Olesen; Susana Perez-Gutthann; Nina Sahlertz Kristiansen; Kwame Appenteng; Stefan de Vogel; John Seeger

A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder

Kelesitse Phiri, Jesper Hallas, Marie Linder, Andrea Margulis, Brandon Suehs, Alejandro Arana, Shahram Bahmanyar, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susana Perez-Gutthann, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John Seeger

Klinisk farmakologi, farmaci og Miljømedicin

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	4352
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	29
Udgave nummer	Suppl. 3
Sider (fra-til)	465
Antal sider	1
ISSN	1053-8569
Status	Udgivet - okt. 2020
Begivenhed	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management - Varighed: 16. sep. 2020 → 17. sep. 2020

Konference

Konference	36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Periode	16/09/2020 → 17/09/2020

Dokumenter og links

https://doi.org/10.1002/pds.5114

Citationsformater

Phiri, K., Hallas, J., Linder, M., Margulis, A., Suehs, B., Arana, A., Bahmanyar, S., Enger, C., Horter, L., Odsbu, I., Olesen, M., Perez-Gutthann, S., Kristiansen, N. S., Appenteng, K., de Vogel, S., & Seeger, J. (2020). A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Pharmacoepidemiology and Drug Safety, 29(Suppl. 3), 465. [4352]. https://doi.org/10.1002/pds.5114

@article{de37d3f31a0e4243a9e36696ab2e41a2,

title = "A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder",

author = "Kelesitse Phiri and Jesper Hallas and Marie Linder and Andrea Margulis and Brandon Suehs and Alejandro Arana and Shahram Bahmanyar and Cheryl Enger and Libby Horter and Ingvild Odsbu and Morten Olesen and Susana Perez-Gutthann and Kristiansen, {Nina Sahlertz} and Kwame Appenteng and {de Vogel}, Stefan and John Seeger",

year = "2020",

month = oct,

language = "English",

volume = "29",

pages = "465",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "Suppl. 3",

note = "36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ; Conference date: 16-09-2020 Through 17-09-2020",

}

Phiri, K, Hallas, J, Linder, M, Margulis, A, Suehs, B, Arana, A, Bahmanyar, S, Enger, C, Horter, L, Odsbu, I, Olesen, M, Perez-Gutthann, S, Kristiansen, NS, Appenteng, K, de Vogel, S & Seeger, J 2020, 'A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder', Pharmacoepidemiology and Drug Safety, bind 29, nr. Suppl. 3, 4352, s. 465. <https://doi.org/10.1002/pds.5114>

TY - ABST

T1 - A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder

AU - Phiri, Kelesitse

AU - Hallas, Jesper

AU - Linder, Marie

AU - Margulis, Andrea

AU - Suehs, Brandon

AU - Arana, Alejandro

AU - Bahmanyar, Shahram

AU - Enger, Cheryl

AU - Horter, Libby

AU - Odsbu, Ingvild

AU - Olesen, Morten

AU - Perez-Gutthann, Susana

AU - Kristiansen, Nina Sahlertz

AU - Appenteng, Kwame

AU - de Vogel, Stefan

AU - Seeger, John

PY - 2020/10

Y1 - 2020/10

M3 - Conference abstract in journal

SN - 1053-8569

VL - 29

SP - 465

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - Suppl. 3

M1 - 4352

T2 - 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Y2 - 16 September 2020 through 17 September 2020

ER -